Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (4): 248-251.
Previous Articles Next Articles
ZHANG Jing, CHU Mingming, LI Letao, ZHANG Rong*
Received:
2019-05-09
Revised:
2019-05-09
Online:
2019-04-20
Published:
2019-05-09
CLC Number:
ZHANG Jing, CHU Mingming, LI Letao, ZHANG Rong. One Case of Epileptic Seizure Induced by Increased Blood Concentration of Cyclosporine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 248-251.
[1] 曲彩红, 苏向阳. 伏立康唑致环孢素血药浓度升高相关癫痫样发作[J]. 药物不良反应杂志, 2010, 12(5):354-356. [2] 江灏, 陈英, 何菊英. 1例纯红细胞再生障碍性贫血患者出现癫痫发作的药源性因素分析[J]. 中国药物应用与监测, 2013, 10(3):181-182. [3] Gaggero R, Haupt R, Fondelli M P, et al.Intractable Epilepsy Secondary to Cyclosporine Toxicity in Children Undergoing Allogeneic Hematopoietic Bone Marrow Transplantation[J]. Journal of Child Neurology, 2006, 21(10):861-866. [4] Vesole A S, Nagahama Y, Granner M A, et al.Drug-resistant epilepsy development following stem cell transplant and cyclosporine neurotoxicity induced seizures: Case report in an adult and analysis of reported cases in the literature[J]. Epilepsy and Behavior Case Reports, 2018, 10:8-13. [5] 李瑞莲, 陈文倩, 张丹, 等. 154例肾病综合征患者环孢素A血药浓度监测及其对疗效、安全性的影响分析[J]. 中国药房, 2018, 29(20):2827-2831. [6] 毕晓莹, 陶沂. 环孢霉素的神经系统毒性[J]. 国际神经病学神经外科学杂志, 2004, 31(6):519-522. [7] 赖针珍. 环孢素致可逆性后部白质脑病综合征1例[J]. 中国乡村医药, 2018, 25(15):38. [8] 吴鹏辉, 谢瑶, 赵卫红, 等. 血液病/肿瘤患儿并发可逆性后部白质脑病综合征[J]. 北京大学学报(医学版), 2018, 50(4):662-665. [9] Valldeoriola F, Graus F, Rimola A, et al.Cyclosporine-associated mutism in liver transplant patients[J]. Neurology, 1996, 46(1):252-254. [10] 韦恩. 药物相互作用原理与临床应用指南[M]. 人民军医出版社,2011. [11] 刘振威, 胡卓汉, 蔡映云. 异烟肼和利福平联合用药对健康成人原代肝细胞CYP450同工酶1A2和3A4活性的影响[J]. 中华结核和呼吸杂志, 2005, 28(11):785-788. [12] Florea N R, Capitano B, Nightingale C H, et al.Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients[J]. Transplantation Proceedings, 2003, 35(8):2873-2877. [13] Gerntholtz T, Pascoe M D, Botha J F, et al.The use of a cyclosporin-ketoconazole combination: Making renal transplantation affordable in developing countries[J]. European Journal of Clinical Pharmacology, 2004, 60(3):143-148. [14] Iyengar A, Kamath N, Phadke K, et al.Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome[J]. Indian Journal of Nephrology, 2013, 23(6):419-423. [15] 易林高, 吴明钗, 黄鹏, 等. HPLC/MS测定环孢素A单用及联用氟康唑的血药浓度[J]. 中国药物应用与监测, 2016, 13(4):211-213. [16] Valenzuela R, Torres J P, Salas C, et al.Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014)[J]. Rev Chilena Infectol, 2017, 34(1):14-18. [17] Masoumi H T, Hadjibabaie M, Vaezi M, et al.Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients[J]. Journal of Research in Pharmacy Practice, 2017, 6(2):77-82. [18] Ishiwata Y, Nagata M, Arai T, et al.Effects of miconazole oral gel on blood concentrations of tacrolimus and cyclosporine: a retrospective observational study[J]. Therapeutic Drug Monitoring, 2016, 38(6):717-721. [19] Romero A.Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients[J]. Clinical Pharmacology & Therapeutics, 2002, 71(4):226-234. [20] 丁春雷, 孙健姿, 张熠, 等. 环孢素浓度异常升高致高尿酸血症1例[J]. 中国药物警戒, 2011, 8(3):190-190. [21] Yang T, Wu X M, Qiu H Q, et al.Adverse drug interactions as a high-risk factor for lethal post-transplant complications in Chinese population[J]. Clinical Transplantation, 2013, 27(2):255-260. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||